LIMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Liminatus Pharma Inc (LIMN) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The stock lacks positive catalysts, has bearish technical indicators, and no significant trading signals or financial data to support a buy decision. Holding off for now is recommended.
The stock shows bearish technical indicators: MACD is below 0 and negatively contracting, RSI is neutral at 32.344, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.115, and resistance is at 0.148. The stock has a 70% chance of minor fluctuations in the short term, with a potential decline of -0.51% over the next month.
NULL identified. No recent news, no significant hedge fund or insider trading activity, and no recent congress trading data.
Bearish technical indicators, lack of trading signals, and no financial or valuation data available.
No financial data available for analysis.
No analyst rating or price target changes available.
